Cargando…
Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia
Evading apoptosis is a hallmark of B-cell chronic lymphocytic leukemia (CLL) cells and an obstacle to current chemotherapeutic approaches. Inhibiting histone deacetylase (HDAC) has emerged as a promising strategy to induce cell death in malignant cells. We have previously reported that the HDAC inhi...
Autores principales: | El-Khoury, V, Pierson, S, Szwarcbart, E, Brons, N H C, Roland, O, Cherrier-De Wilde, S, Plawny, L, Van Dyck, E, Berchem, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131250/ https://www.ncbi.nlm.nih.gov/pubmed/24418989 http://dx.doi.org/10.1038/leu.2014.19 |
Ejemplares similares
-
Histone deacetylase inhibitor MGCD0103 causes cell cycle arrest, apoptosis, and autophagy in liver cancer cells
por: Liao, Bo, et al.
Publicado: (2020) -
The Effect of MGCD0103 on CYP450 Isoforms Activity of Rats by Cocktail Method
por: Cai, Jinzhang, et al.
Publicado: (2015) -
MGCD0103, a selective histone deacetylase inhibitor, coameliorates oligomeric Aβ(25‐35)‐induced anxiety and cognitive deficits in a mouse model
por: Huang, Hei‐Jen, et al.
Publicado: (2018) -
MGCD0103 induces apoptosis and simultaneously increases the expression of NF-κB and PD-L1 in classical Hodgkin's lymphoma
por: Huang, Renhong, et al.
Publicado: (2018) -
In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting
por: Kaya Çakir, Hacer, et al.
Publicado: (2021)